| 000 | 01761 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517191250.0 | ||
| 264 | 0 | _c20181211 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a1532-3064 | ||
| 024 | 7 |
_a10.1016/j.rmed.2017.10.023 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSavaria, François | |
| 245 | 0 | 0 |
_aPolypharmacy, chronic kidney disease, and benign prostatic hyperplasia in patients with chronic obstructive pulmonary disease newly treated with long-acting anticholinergics. _h[electronic resource] |
| 260 |
_bRespiratory medicine _c11 2017 |
||
| 300 |
_a195-202 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCanada _xepidemiology |
| 650 | 0 | 4 |
_aCholinergic Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aComorbidity |
| 650 | 0 | 4 |
_aDelayed-Action Preparations _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIncidence |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolypharmacy |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _xdiagnosis |
| 650 | 0 | 4 |
_aPulmonary Disease, Chronic Obstructive _xdrug therapy |
| 650 | 0 | 4 |
_aRenal Insufficiency, Chronic _xdiagnosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aUrinary Retention _xchemically induced |
| 700 | 1 | _aBeauchesne, Marie-France | |
| 700 | 1 | _aForget, Amélie | |
| 700 | 1 | _aBlais, Lucie | |
| 773 | 0 |
_tRespiratory medicine _gvol. 132 _gp. 195-202 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.rmed.2017.10.023 _zAvailable from publisher's website |
| 999 |
_c27877728 _d27877728 |
||